» Articles » PMID: 35616598

Staged Revision Still Works for Chronic and Deep Infection of Total Elbow Arthroplasty?

Overview
Journal SICOT J
Publisher EDP Sciences
Specialty Orthopedics
Date 2022 May 26
PMID 35616598
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Infected total elbow arthroplasty (TEA) is challenging. We evaluate the clinical and radiologic outcomes for chronic and deep infection of TEA with two-stage revision surgery.

Methods: A total of 10 elbows were included in the study. The mean age was 69.1 ± 15 years (range, 34-83 years). The mean follow-up was 62 (range, 24-108) months. The clinical outcomes were assessed using a visual analog scale (VAS), range of motion (ROM) arc, and Mayo elbow performance score (MEPS). Moreover, radiographic outcomes, time to revision, pathogenic bacteria, preoperative complications, and disease period were evaluated.

Results: Mean preoperative VAS score of 6.1 had improved to 3.3. Mean preoperative ROM was 68° (flexion-extension), which improved to 86.7°. Mean preoperative MEPS was 46 (range, 0-70), which improved to 75.5 (range, 35-85). The mean disease duration was 8.4 months (range, 5-20 months). The most common causative organism was methicillin-resistant Staphylococcus aureus. The second revision rate was 80% at the final follow-up. Radiographic outcome at final follow-up showed that 3 (30%) of 10 patients exhibited radiolucency evidence around the components. Three patients showed nonprogressive radiolucency around the implant interfaces without other indications of infection at the most recent follow-up.

Conclusion: In patients with chronic and deep infection of TEA, two-stage revision can be an affordable option for eradication of the infection, relieving pain, and restoring joint function. However, the high second revision rate owing to bone and soft-tissue deficits remains a critical issue.

Level Of Evidence: Level IV, Case series, Treatment study.

Citing Articles

Revision total elbow arthroplasty is associated with a high rate of 30-day complications: A descriptive analysis of a national database.

El-Najjar D, Mehta A, Gupta P, Peterson J, Marigi E, Rogalski B Shoulder Elbow. 2024; :17585732241269001.

PMID: 39552697 PMC: 11562222. DOI: 10.1177/17585732241269001.


Elbow Arthroplasty: A Concise Literature Update.

Rodriguez-Merchan E, Kachooei A, Tabeayo E Arch Bone Jt Surg. 2023; 11(7):465-472.

PMID: 37538135 PMC: 10394745. DOI: 10.22038/ABJS.2023.71082.3323.


Infectious disease specialists and teamwork strategies worldwide: the World Association against Infection in Orthopedics and Trauma (WAIOT) and SICOT continue to cooperate in fighting musculoskeletal infections.

Romano C, Tsantes A, Papadopoulos D, Tsuchiya H, Benzakour T, Benevenia J SICOT J. 2022; 8:E1.

PMID: 35969121 PMC: 9377213. DOI: 10.1051/sicotj/2022031.

References
1.
Lim P, Chang L, Thian E . Development of nanosized silver-substituted apatite for biomedical applications: A review. Nanomedicine. 2015; 11(6):1331-44. DOI: 10.1016/j.nano.2015.03.016. View

2.
Kok T, Agrawal N, Sathappan S, Chen W . Risk factors for early implant-related surgical site infection. J Orthop Surg (Hong Kong). 2016; 24(1):72-6. DOI: 10.1177/230949901602400117. View

3.
Parvizi J, Adeli B, Zmistowski B, Restrepo C, Greenwald A . Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection. J Bone Joint Surg Am. 2012; 94(14):e104. DOI: 10.2106/JBJS.K.01417. View

4.
Yoon H, Cho S, Lee D, Kang B, Lee S, Moon D . A Review of the Literature on Culture-Negative Periprosthetic Joint Infection: Epidemiology, Diagnosis and Treatment. Knee Surg Relat Res. 2017; 29(3):155-164. PMC: 5596406. DOI: 10.5792/ksrr.16.034. View

5.
Viveen J, Prkic A, Koenraadt K, Kodde I, The B, Eygendaal D . Clinical and radiographic outcome of revision surgery of total elbow prosthesis: midterm results in 19 cases. J Shoulder Elbow Surg. 2017; 26(4):716-722. DOI: 10.1016/j.jse.2016.10.010. View